| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Neuroendocrine Tumors | 20 | 2020 | 241 | 4.36 | Why? |
| Acromegaly | 15 | 2019 | 79 | 3.69 | Why? |
| Somatostatin | 10 | 2020 | 49 | 3.19 | Why? |
| Human Growth Hormone | 17 | 2017 | 120 | 2.76 | Why? |
| Insulin-Like Growth Factor I | 13 | 2019 | 119 | 2.41 | Why? |
| Metabolic Syndrome | 7 | 2021 | 810 | 1.63 | Why? |
| Antineoplastic Agents | 12 | 2020 | 3550 | 1.55 | Why? |
| Obesity | 14 | 2021 | 7388 | 1.52 | Why? |
| Dopamine Agonists | 4 | 2018 | 61 | 1.31 | Why? |
| Insulin Resistance | 7 | 2018 | 669 | 1.27 | Why? |
| Pancreatic Neoplasms | 9 | 2020 | 609 | 1.24 | Why? |
| Diet, Mediterranean | 10 | 2021 | 351 | 1.22 | Why? |
| Multiple Endocrine Neoplasia Type 1 | 3 | 2020 | 10 | 1.21 | Why? |
| Everolimus | 5 | 2019 | 215 | 1.11 | Why? |
| Thyroid Neoplasms | 6 | 2018 | 422 | 1.03 | Why? |
| Octreotide | 8 | 2019 | 56 | 1.03 | Why? |
| Hyperprolactinemia | 3 | 2021 | 19 | 1.00 | Why? |
| Cushing Syndrome | 4 | 2020 | 76 | 1.00 | Why? |
| Pituitary Neoplasms | 7 | 2019 | 130 | 1.00 | Why? |
| Vitamin D | 11 | 2021 | 2904 | 0.96 | Why? |
| Vitamin D Deficiency | 8 | 2020 | 1782 | 0.93 | Why? |
| Environmental Pollutants | 5 | 2018 | 320 | 0.91 | Why? |
| Carcinoma, Medullary | 2 | 2018 | 12 | 0.86 | Why? |
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2012 | 6 | 0.82 | Why? |
| Carcinogens | 2 | 2018 | 33 | 0.79 | Why? |
| Nutritionists | 2 | 2017 | 82 | 0.78 | Why? |
| Anti-Obesity Agents | 2 | 2019 | 52 | 0.78 | Why? |
| Premenopause | 2 | 2019 | 63 | 0.76 | Why? |
| Hyperparathyroidism, Secondary | 1 | 2019 | 47 | 0.76 | Why? |
| Bone Remodeling | 1 | 2019 | 59 | 0.76 | Why? |
| Hazardous Waste Sites | 1 | 2018 | 4 | 0.75 | Why? |
| Nutrition Policy | 1 | 2020 | 132 | 0.74 | Why? |
| Incineration | 1 | 2018 | 43 | 0.72 | Why? |
| Endocrine Disruptors | 2 | 2018 | 50 | 0.72 | Why? |
| Pituitary ACTH Hypersecretion | 2 | 2018 | 44 | 0.71 | Why? |
| Peptides, Cyclic | 1 | 2020 | 223 | 0.70 | Why? |
| Watchful Waiting | 1 | 2020 | 276 | 0.69 | Why? |
| Cholelithiasis | 1 | 2017 | 47 | 0.69 | Why? |
| Osteoporosis | 3 | 2021 | 410 | 0.68 | Why? |
| Neoplastic Cells, Circulating | 1 | 2017 | 68 | 0.64 | Why? |
| Adrenal Glands | 1 | 2017 | 98 | 0.63 | Why? |
| Carcinogenesis | 1 | 2018 | 236 | 0.62 | Why? |
| Weight Loss | 2 | 2018 | 826 | 0.61 | Why? |
| Ergolines | 1 | 2014 | 1 | 0.60 | Why? |
| Post-Exposure Prophylaxis | 1 | 2020 | 472 | 0.59 | Why? |
| Prolactinoma | 1 | 2014 | 5 | 0.59 | Why? |
| Atherosclerosis | 3 | 2018 | 768 | 0.59 | Why? |
| Body Composition | 5 | 2018 | 414 | 0.57 | Why? |
| Calcium | 2 | 2019 | 708 | 0.55 | Why? |
| Feeding Behavior | 5 | 2021 | 1909 | 0.55 | Why? |
| Hypoglycemia | 2 | 2017 | 406 | 0.52 | Why? |
| Skinfold Thickness | 1 | 2012 | 13 | 0.51 | Why? |
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2012 | 12 | 0.51 | Why? |
| Epigenesis, Genetic | 2 | 2019 | 711 | 0.49 | Why? |
| Biomarkers, Tumor | 3 | 2017 | 1314 | 0.49 | Why? |
| Diabetic Retinopathy | 1 | 2017 | 347 | 0.49 | Why? |
| Gestational Age | 1 | 2017 | 1488 | 0.46 | Why? |
| Waist Circumference | 1 | 2012 | 199 | 0.45 | Why? |
| Nutritional Status | 5 | 2018 | 1403 | 0.43 | Why? |
| Cardiovascular System | 1 | 2019 | 750 | 0.42 | Why? |
| Cardiovascular Diseases | 5 | 2019 | 11497 | 0.41 | Why? |
| Heart Valve Diseases | 1 | 2014 | 355 | 0.41 | Why? |
| Health Literacy | 1 | 2020 | 1078 | 0.40 | Why? |
| Hyperinsulinism | 3 | 2018 | 27 | 0.40 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.38 | Why? |
| Hypogonadism | 4 | 2019 | 196 | 0.38 | Why? |
| Dwarfism, Pituitary | 1 | 2008 | 4 | 0.38 | Why? |
| Stomach Neoplasms | 3 | 2019 | 477 | 0.38 | Why? |
| Intestinal Neoplasms | 2 | 2019 | 42 | 0.38 | Why? |
| Fertility | 3 | 2017 | 367 | 0.38 | Why? |
| Molecular Targeted Therapy | 2 | 2017 | 1579 | 0.37 | Why? |
| Health Care Costs | 1 | 2017 | 1007 | 0.36 | Why? |
| Diabetes Complications | 2 | 2018 | 2358 | 0.36 | Why? |
| Adipocytes | 3 | 2019 | 173 | 0.36 | Why? |
| Drug Prescriptions | 1 | 2017 | 1062 | 0.36 | Why? |
| Physician's Role | 1 | 2017 | 853 | 0.35 | Why? |
| Electric Impedance | 4 | 2018 | 283 | 0.35 | Why? |
| Humans | 123 | 2021 | 930598 | 0.34 | Why? |
| Quarantine | 6 | 2021 | 18418 | 0.33 | Why? |
| Glucocorticoids | 2 | 2020 | 4431 | 0.33 | Why? |
| Neoplasms | 5 | 2018 | 17251 | 0.33 | Why? |
| Body Height | 2 | 2017 | 100 | 0.33 | Why? |
| Carcinoma, Papillary | 2 | 2017 | 76 | 0.32 | Why? |
| Blood Glucose | 2 | 2018 | 3642 | 0.32 | Why? |
| Insulin | 5 | 2018 | 1316 | 0.32 | Why? |
| Polycystic Ovary Syndrome | 4 | 2018 | 151 | 0.31 | Why? |
| Diarrhea | 2 | 2017 | 2743 | 0.31 | Why? |
| Kallmann Syndrome | 2 | 2017 | 3 | 0.31 | Why? |
| Phenols | 2 | 2018 | 226 | 0.31 | Why? |
| Arteriosclerosis | 1 | 2005 | 50 | 0.30 | Why? |
| Environmental Monitoring | 1 | 2018 | 3143 | 0.29 | Why? |
| Bone Density | 3 | 2017 | 335 | 0.29 | Why? |
| Italy | 18 | 2021 | 38444 | 0.29 | Why? |
| Proto-Oncogene Proteins | 2 | 2018 | 340 | 0.29 | Why? |
| Benzhydryl Compounds | 2 | 2018 | 240 | 0.29 | Why? |
| Air Pollution | 2 | 2020 | 3504 | 0.28 | Why? |
| Adenoma | 3 | 2019 | 215 | 0.28 | Why? |
| Body Mass Index | 7 | 2020 | 4306 | 0.28 | Why? |
| Growth Disorders | 3 | 2017 | 91 | 0.27 | Why? |
| Anthropometry | 4 | 2018 | 233 | 0.27 | Why? |
| Adiposity | 3 | 2018 | 329 | 0.27 | Why? |
| Biomarkers | 10 | 2019 | 23361 | 0.26 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.26 | Why? |
| Growth Hormone-Releasing Hormone | 4 | 2007 | 17 | 0.26 | Why? |
| Hypertension | 3 | 2017 | 8895 | 0.26 | Why? |
| Animals | 22 | 2020 | 78931 | 0.26 | Why? |
| Breast Neoplasms | 2 | 2019 | 3633 | 0.25 | Why? |
| Bone and Bones | 2 | 2017 | 235 | 0.25 | Why? |
| Environmental Exposure | 3 | 2018 | 1558 | 0.25 | Why? |
| Hypopituitarism | 3 | 2008 | 64 | 0.25 | Why? |
| Antineoplastic Agents, Hormonal | 3 | 2017 | 203 | 0.25 | Why? |
| Adult | 53 | 2021 | 244371 | 0.24 | Why? |
| Life Style | 5 | 2021 | 2708 | 0.24 | Why? |
| Hormone Replacement Therapy | 2 | 2017 | 146 | 0.23 | Why? |
| Female | 66 | 2021 | 380317 | 0.23 | Why? |
| Male | 63 | 2021 | 367725 | 0.22 | Why? |
| Homeostasis | 3 | 2017 | 582 | 0.22 | Why? |
| Infertility, Female | 2 | 2017 | 150 | 0.21 | Why? |
| Diabetes Mellitus, Type 2 | 4 | 2018 | 6166 | 0.21 | Why? |
| Myocardial Infarction | 1 | 2016 | 3361 | 0.21 | Why? |
| Heart Failure | 2 | 2019 | 6638 | 0.21 | Why? |
| Morbidity | 2 | 2019 | 1426 | 0.21 | Why? |
| Middle Aged | 48 | 2021 | 270681 | 0.20 | Why? |
| Endocrine System Diseases | 2 | 2017 | 282 | 0.20 | Why? |
| Health Surveys | 1 | 2011 | 2841 | 0.20 | Why? |
| Adipogenesis | 1 | 2019 | 38 | 0.20 | Why? |
| Gastritis, Atrophic | 1 | 2019 | 20 | 0.20 | Why? |
| Thyroid Nodule | 2 | 2018 | 70 | 0.20 | Why? |
| Diethylhexyl Phthalate | 1 | 2018 | 10 | 0.20 | Why? |
| Nutrition Assessment | 3 | 2018 | 527 | 0.20 | Why? |
| Benzopyrans | 1 | 2019 | 39 | 0.19 | Why? |
| Klinefelter Syndrome | 1 | 2019 | 21 | 0.19 | Why? |
| Prognosis | 15 | 2020 | 32490 | 0.19 | Why? |
| Methylamines | 1 | 2018 | 23 | 0.19 | Why? |
| Arginine | 3 | 2007 | 377 | 0.19 | Why? |
| Bupropion | 1 | 2018 | 26 | 0.19 | Why? |
| Psychotherapy, Brief | 1 | 2019 | 34 | 0.19 | Why? |
| Somatomedins | 1 | 2018 | 7 | 0.19 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.19 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.19 | Why? |
| Thyroid Gland | 2 | 2017 | 516 | 0.19 | Why? |
| Adenocarcinoma, Follicular | 1 | 2018 | 21 | 0.19 | Why? |
| Benzazepines | 1 | 2018 | 49 | 0.19 | Why? |
| Carcinoma, Merkel Cell | 1 | 2019 | 35 | 0.19 | Why? |
| Receptors, Somatostatin | 1 | 2018 | 19 | 0.19 | Why? |
| Coronavirus Infections | 9 | 2020 | 253789 | 0.19 | Why? |
| Liraglutide | 1 | 2018 | 47 | 0.19 | Why? |
| Heart Diseases | 2 | 2018 | 3503 | 0.19 | Why? |
| Adrenal Cortex Neoplasms | 1 | 2018 | 28 | 0.19 | Why? |
| Pandemics | 12 | 2021 | 389249 | 0.19 | Why? |
| PAX8 Transcription Factor | 1 | 2017 | 7 | 0.18 | Why? |
| Drinking | 1 | 2018 | 69 | 0.18 | Why? |
| Thyroid Dysgenesis | 1 | 2017 | 4 | 0.18 | Why? |
| HSP40 Heat-Shock Proteins | 1 | 2017 | 12 | 0.18 | Why? |
| Zollinger-Ellison Syndrome | 1 | 2017 | 1 | 0.18 | Why? |
| Naltrexone | 1 | 2018 | 56 | 0.18 | Why? |
| Gastrinoma | 1 | 2017 | 2 | 0.18 | Why? |
| Diethylstilbestrol | 1 | 2017 | 2 | 0.18 | Why? |
| Thyroid Nuclear Factor 1 | 1 | 2017 | 12 | 0.18 | Why? |
| Chromatin | 1 | 2019 | 107 | 0.18 | Why? |
| Humulus | 1 | 2017 | 5 | 0.18 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.18 | Why? |
| Chromogranin A | 1 | 2017 | 15 | 0.18 | Why? |
| Dietary Carbohydrates | 1 | 2018 | 64 | 0.18 | Why? |
| Hypoparathyroidism | 1 | 2018 | 36 | 0.18 | Why? |
| Tumor Burden | 1 | 2020 | 369 | 0.18 | Why? |
| Waste Disposal Facilities | 1 | 2018 | 57 | 0.18 | Why? |
| Germ-Line Mutation | 1 | 2018 | 86 | 0.18 | Why? |
| Thyroid Epithelial Cells | 1 | 2017 | 3 | 0.18 | Why? |
| Radioisotopes | 1 | 2017 | 29 | 0.17 | Why? |
| Receptors, Peptide | 1 | 2017 | 32 | 0.17 | Why? |
| Diabetes Mellitus | 3 | 2018 | 8207 | 0.17 | Why? |
| Gonadal Steroid Hormones | 1 | 2020 | 328 | 0.17 | Why? |
| Sirtuins | 1 | 2017 | 27 | 0.17 | Why? |
| Particulate Matter | 2 | 2020 | 3249 | 0.17 | Why? |
| Social Environment | 1 | 2021 | 389 | 0.17 | Why? |
| Carcinoid Tumor | 1 | 2017 | 46 | 0.17 | Why? |
| Glucagon-Like Peptide 1 | 1 | 2017 | 83 | 0.17 | Why? |
| Bone Diseases, Metabolic | 2 | 2017 | 64 | 0.17 | Why? |
| Coffee | 1 | 2018 | 79 | 0.17 | Why? |
| Carbohydrate Metabolism | 1 | 2017 | 44 | 0.17 | Why? |
| Adipose Tissue | 2 | 2017 | 612 | 0.17 | Why? |
| Risk Factors | 16 | 2020 | 71621 | 0.17 | Why? |
| Sunlight | 2 | 2017 | 287 | 0.17 | Why? |
| Young Adult | 21 | 2021 | 93724 | 0.17 | Why? |
| Thyrotropin | 1 | 2019 | 262 | 0.17 | Why? |
| Dietary Supplements | 3 | 2019 | 2251 | 0.17 | Why? |
| Protein-Tyrosine Kinases | 1 | 2018 | 158 | 0.16 | Why? |
| Infant, Small for Gestational Age | 1 | 2017 | 151 | 0.16 | Why? |
| Hand Strength | 1 | 2018 | 202 | 0.16 | Why? |
| Aged | 29 | 2021 | 215776 | 0.16 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2017 | 159 | 0.16 | Why? |
| Cardiovascular Physiological Phenomena | 1 | 2017 | 70 | 0.16 | Why? |
| Cytodiagnosis | 1 | 2017 | 104 | 0.16 | Why? |
| Hashimoto Disease | 1 | 2017 | 74 | 0.16 | Why? |
| Cadmium | 1 | 2017 | 105 | 0.16 | Why? |
| Prevalence | 7 | 2021 | 25773 | 0.16 | Why? |
| Mitochondrial Proteins | 1 | 2017 | 152 | 0.16 | Why? |
| Biopsy, Fine-Needle | 1 | 2017 | 274 | 0.16 | Why? |
| Prediabetic State | 1 | 2019 | 200 | 0.16 | Why? |
| Osteoporotic Fractures | 1 | 2019 | 175 | 0.16 | Why? |
| Glycopeptides | 1 | 2018 | 199 | 0.16 | Why? |
| Prostatic Hyperplasia | 1 | 1998 | 161 | 0.16 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.16 | Why? |
| Optic Chiasm | 1 | 2015 | 6 | 0.15 | Why? |
| Cell Survival | 2 | 2019 | 1581 | 0.15 | Why? |
| Lipid Metabolism | 2 | 2019 | 572 | 0.15 | Why? |
| Hormones | 4 | 2017 | 66 | 0.15 | Why? |
| Patient Compliance | 4 | 2019 | 1468 | 0.15 | Why? |
| Protein Kinase Inhibitors | 2 | 2018 | 1585 | 0.15 | Why? |
| Ovulation Induction | 2 | 2006 | 58 | 0.15 | Why? |
| Metformin | 2 | 2018 | 640 | 0.15 | Why? |
| Quercetin | 1 | 2019 | 297 | 0.15 | Why? |
| Hospitalization | 2 | 2017 | 54280 | 0.15 | Why? |
| Survival Rate | 3 | 2019 | 9206 | 0.15 | Why? |
| Nerve Compression Syndromes | 1 | 2015 | 25 | 0.15 | Why? |
| Databases, Factual | 4 | 2019 | 6248 | 0.15 | Why? |
| Overweight | 2 | 2019 | 916 | 0.15 | Why? |
| Chemoprevention | 1 | 2020 | 585 | 0.15 | Why? |
| Androgens | 1 | 2018 | 267 | 0.15 | Why? |
| Epidemiologic Studies | 1 | 2018 | 554 | 0.15 | Why? |
| Obesity, Morbid | 1 | 2006 | 1340 | 0.14 | Why? |
| B7-H1 Antigen | 1 | 2019 | 541 | 0.14 | Why? |
| Glycogen Storage Disease Type I | 1 | 2013 | 1 | 0.14 | Why? |
| Adrenal Insufficiency | 1 | 2017 | 190 | 0.14 | Why? |
| Nerve Fibers | 1 | 2015 | 73 | 0.14 | Why? |
| Diagnostic Techniques, Endocrine | 1 | 2014 | 12 | 0.14 | Why? |
| Refuse Disposal | 1 | 2018 | 183 | 0.14 | Why? |
| Endoplasmic Reticulum Stress | 1 | 2017 | 253 | 0.14 | Why? |
| Retinal Ganglion Cells | 1 | 2015 | 80 | 0.14 | Why? |
| Dyslipidemias | 1 | 2021 | 791 | 0.14 | Why? |
| Reproduction | 1 | 2017 | 259 | 0.14 | Why? |
| Environmental Pollution | 1 | 2018 | 344 | 0.13 | Why? |
| Follow-Up Studies | 5 | 2020 | 17020 | 0.13 | Why? |
| Adolescent | 21 | 2021 | 86841 | 0.13 | Why? |
| Esophageal Neoplasms | 1 | 2019 | 357 | 0.13 | Why? |
| Cell Proliferation | 2 | 2018 | 1973 | 0.13 | Why? |
| Ethmoid Bone | 1 | 2013 | 34 | 0.13 | Why? |
| Diet | 4 | 2018 | 2052 | 0.13 | Why? |
| Hidradenitis Suppurativa | 1 | 2018 | 309 | 0.13 | Why? |
| Psoriasis | 2 | 2018 | 1739 | 0.13 | Why? |
| Spleen | 1 | 2017 | 877 | 0.13 | Why? |
| Non-alcoholic Fatty Liver Disease | 2 | 2020 | 907 | 0.13 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.13 | Why? |
| Sleep Apnea Syndromes | 1 | 2017 | 282 | 0.13 | Why? |
| Stroke | 1 | 2016 | 8839 | 0.13 | Why? |
| Malnutrition | 2 | 2020 | 932 | 0.13 | Why? |
| Glucose | 1 | 2017 | 573 | 0.13 | Why? |
| Treatment Outcome | 10 | 2020 | 51732 | 0.13 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.12 | Why? |
| Biological Therapy | 1 | 2017 | 456 | 0.12 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2018 | 1573 | 0.12 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.12 | Why? |
| Cognition Disorders | 1 | 2017 | 574 | 0.12 | Why? |
| Metabolic Diseases | 1 | 2018 | 505 | 0.12 | Why? |
| Testis | 1 | 2017 | 566 | 0.12 | Why? |
| Granulocyte Colony-Stimulating Factor | 1 | 2013 | 264 | 0.12 | Why? |
| Dermatologists | 1 | 2017 | 435 | 0.11 | Why? |
| Selenium | 1 | 2017 | 412 | 0.11 | Why? |
| Vitamins | 2 | 2021 | 1208 | 0.11 | Why? |
| Patient Participation | 1 | 2019 | 829 | 0.11 | Why? |
| Cardiomyopathies | 1 | 2001 | 997 | 0.11 | Why? |
| Case-Control Studies | 6 | 2020 | 17671 | 0.11 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.11 | Why? |
| Heart | 1 | 2001 | 1791 | 0.11 | Why? |
| Lung Neoplasms | 2 | 2019 | 3228 | 0.11 | Why? |
| Contrast Media | 1 | 2017 | 1011 | 0.11 | Why? |
| Pentagastrin | 1 | 2009 | 6 | 0.11 | Why? |
| Skull Base | 1 | 2013 | 246 | 0.10 | Why? |
| Liver Neoplasms | 2 | 2017 | 1666 | 0.10 | Why? |
| Time Factors | 5 | 2020 | 31397 | 0.10 | Why? |
| Olfactory Bulb | 1 | 2013 | 333 | 0.10 | Why? |
| Clomiphene | 2 | 2006 | 9 | 0.10 | Why? |
| Sex Distribution | 1 | 2017 | 2083 | 0.10 | Why? |
| Ultrasonography | 3 | 2017 | 4409 | 0.10 | Why? |
| Dose-Response Relationship, Drug | 1 | 2018 | 3776 | 0.10 | Why? |
| Tunica Media | 1 | 2008 | 13 | 0.10 | Why? |
| Reference Values | 2 | 2005 | 795 | 0.09 | Why? |
| Sleep Wake Disorders | 1 | 2020 | 1463 | 0.09 | Why? |
| Drug Combinations | 1 | 2018 | 3852 | 0.09 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2011 | 219 | 0.09 | Why? |
| Autoimmune Diseases | 3 | 2017 | 1996 | 0.09 | Why? |
| Vasopressins | 2 | 2018 | 70 | 0.09 | Why? |
| Carotid Artery, Common | 1 | 2008 | 49 | 0.09 | Why? |
| Child | 10 | 2021 | 70012 | 0.09 | Why? |
| Diabetes Insipidus | 2 | 1999 | 33 | 0.09 | Why? |
| Calcitonin | 1 | 2009 | 201 | 0.09 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.09 | Why? |
| Double-Blind Method | 2 | 2017 | 5988 | 0.09 | Why? |
| Enzyme Inhibitors | 1 | 2018 | 1881 | 0.09 | Why? |
| Arrhythmias, Cardiac | 1 | 2001 | 2510 | 0.09 | Why? |
| Health Status | 1 | 2021 | 3259 | 0.08 | Why? |
| Drug Design | 2 | 2017 | 2627 | 0.08 | Why? |
| Sleep | 1 | 2020 | 2695 | 0.08 | Why? |
| Tomography, Optical Coherence | 1 | 2015 | 1008 | 0.08 | Why? |
| Hydrocortisone | 1 | 2017 | 1790 | 0.08 | Why? |
| Prospective Studies | 9 | 2020 | 43301 | 0.08 | Why? |
| Neoplasm Grading | 2 | 2018 | 400 | 0.08 | Why? |
| Age Distribution | 1 | 2017 | 3567 | 0.08 | Why? |
| Drug Therapy, Combination | 2 | 2018 | 7268 | 0.08 | Why? |
| Disease-Free Survival | 3 | 2018 | 1654 | 0.08 | Why? |
| Diathermy | 1 | 2006 | 13 | 0.08 | Why? |
| Receptors, Calcitriol | 2 | 2017 | 102 | 0.08 | Why? |
| Waist-Hip Ratio | 1 | 2006 | 50 | 0.08 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.08 | Why? |
| Exercise | 4 | 2021 | 6771 | 0.08 | Why? |
| Residence Characteristics | 1 | 2017 | 1927 | 0.08 | Why? |
| Anovulation | 1 | 2005 | 2 | 0.08 | Why? |
| Plant Extracts | 1 | 2017 | 1514 | 0.08 | Why? |
| Tunica Intima | 1 | 2005 | 27 | 0.08 | Why? |
| Neoplasms, Unknown Primary | 1 | 2005 | 28 | 0.07 | Why? |
| Carcinoma, Small Cell | 1 | 2005 | 16 | 0.07 | Why? |
| Inflammation | 2 | 2018 | 13255 | 0.07 | Why? |
| Comorbidity | 3 | 2019 | 34796 | 0.07 | Why? |
| Parkinson Disease | 1 | 2017 | 1414 | 0.07 | Why? |
| Immunotherapy | 1 | 2019 | 2421 | 0.07 | Why? |
| Skin Neoplasms | 1 | 2019 | 1679 | 0.07 | Why? |
| Liver | 2 | 2017 | 4007 | 0.07 | Why? |
| Neoplasm Metastasis | 2 | 2018 | 682 | 0.07 | Why? |
| Adrenal Gland Neoplasms | 1 | 2005 | 70 | 0.07 | Why? |
| Retrospective Studies | 10 | 2019 | 105322 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.07 | Why? |
| Mice | 2 | 2020 | 21357 | 0.06 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.06 | Why? |
| Carotid Arteries | 1 | 2005 | 182 | 0.06 | Why? |
| Glucose Tolerance Test | 2 | 2017 | 238 | 0.06 | Why? |
| Phenotype | 3 | 2019 | 4037 | 0.06 | Why? |
| Logistic Models | 4 | 2019 | 9089 | 0.06 | Why? |
| Child, Preschool | 5 | 2021 | 36283 | 0.06 | Why? |
| Radionuclide Angiography | 1 | 2001 | 5 | 0.06 | Why? |
| Cross-Sectional Studies | 9 | 2018 | 53120 | 0.06 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.06 | Why? |
| Brain | 1 | 2019 | 5133 | 0.06 | Why? |
| Autoimmunity | 1 | 2008 | 841 | 0.06 | Why? |
| Hormone Antagonists | 1 | 2020 | 29 | 0.06 | Why? |
| Linear Models | 2 | 2018 | 1914 | 0.05 | Why? |
| Body Weight | 2 | 2017 | 1074 | 0.05 | Why? |
| Pituitary Gland, Posterior | 1 | 1999 | 2 | 0.05 | Why? |
| Pregnancy | 4 | 2017 | 23879 | 0.05 | Why? |
| Adrenocorticotropic Hormone | 2 | 2017 | 107 | 0.05 | Why? |
| Physical Endurance | 1 | 2001 | 107 | 0.05 | Why? |
| Europe | 1 | 2017 | 12702 | 0.05 | Why? |
| Registries | 2 | 2017 | 12327 | 0.05 | Why? |
| CCAAT-Enhancer-Binding Proteins | 1 | 2019 | 17 | 0.05 | Why? |
| 3T3-L1 Cells | 1 | 2019 | 29 | 0.05 | Why? |
| Lymphatic Metastasis | 2 | 2017 | 537 | 0.05 | Why? |
| Rats | 2 | 2018 | 2764 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2019 | 8041 | 0.05 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.05 | Why? |
| Chlorobenzenes | 1 | 2018 | 35 | 0.05 | Why? |
| Ovarian Neoplasms | 1 | 2005 | 465 | 0.05 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.05 | Why? |
| Arginine Vasopressin | 1 | 2018 | 14 | 0.05 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.05 | Why? |
| Phthalic Acids | 1 | 2018 | 40 | 0.05 | Why? |
| Glucagon | 1 | 2018 | 52 | 0.05 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.05 | Why? |
| Hyperandrogenism | 1 | 2018 | 36 | 0.05 | Why? |
| Enteroendocrine Cells | 1 | 2017 | 5 | 0.05 | Why? |
| Gastrointestinal Hormones | 1 | 2017 | 7 | 0.05 | Why? |
| Regression Analysis | 1 | 2006 | 2484 | 0.05 | Why? |
| PPAR gamma | 1 | 2019 | 102 | 0.05 | Why? |
| Hypoglycemic Agents | 3 | 2018 | 2165 | 0.05 | Why? |
| Public Health | 3 | 2020 | 16359 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.05 | Why? |
| Practice Patterns, Physicians' | 1 | 2017 | 4927 | 0.05 | Why? |
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2017 | 19 | 0.05 | Why? |
| Beer | 1 | 2017 | 14 | 0.05 | Why? |
| Splenomegaly | 1 | 2017 | 43 | 0.05 | Why? |
| Heartburn | 1 | 2017 | 20 | 0.05 | Why? |
| Food Quality | 1 | 2017 | 49 | 0.04 | Why? |
| Taste Buds | 1 | 2017 | 25 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2019 | 161 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Lipids | 1 | 2005 | 1079 | 0.04 | Why? |
| Bcl-2-Like Protein 11 | 1 | 2017 | 4 | 0.04 | Why? |
| Parathyroid Hormone | 1 | 2018 | 98 | 0.04 | Why? |
| Caspase 7 | 1 | 2017 | 30 | 0.04 | Why? |
| Addison Disease | 1 | 2017 | 24 | 0.04 | Why? |
| Tunicamycin | 1 | 2017 | 9 | 0.04 | Why? |
| Skin Physiological Phenomena | 1 | 2017 | 27 | 0.04 | Why? |
| Biological Availability | 1 | 2019 | 388 | 0.04 | Why? |
| Headache | 1 | 2008 | 2257 | 0.04 | Why? |
| Phosphates | 1 | 2018 | 135 | 0.04 | Why? |
| Growth Hormone | 2 | 1995 | 29 | 0.04 | Why? |
| Echocardiography, Doppler | 2 | 2017 | 269 | 0.04 | Why? |
| Aminopyridines | 1 | 2018 | 121 | 0.04 | Why? |
| Corticotropin-Releasing Hormone | 1 | 1996 | 15 | 0.04 | Why? |
| ROC Curve | 3 | 2018 | 6024 | 0.04 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.04 | Why? |
| Rats, Wistar | 1 | 2019 | 621 | 0.04 | Why? |
| Empty Sella Syndrome | 1 | 1996 | 4 | 0.04 | Why? |
| Spermatogenesis | 1 | 2017 | 126 | 0.04 | Why? |
| Signal Transduction | 3 | 2018 | 7207 | 0.04 | Why? |
| Caspase 3 | 1 | 2017 | 218 | 0.04 | Why? |
| Hypocalcemia | 1 | 2018 | 120 | 0.04 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2017 | 127 | 0.04 | Why? |
| Graves Disease | 1 | 2017 | 61 | 0.04 | Why? |
| Habits | 1 | 2018 | 334 | 0.04 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.04 | Why? |
| Nutritional Physiological Phenomena | 1 | 2017 | 100 | 0.04 | Why? |
| Semen Analysis | 1 | 2017 | 235 | 0.04 | Why? |
| Morpholines | 1 | 2018 | 351 | 0.04 | Why? |
| Obesity, Abdominal | 1 | 2018 | 167 | 0.04 | Why? |
| Histones | 1 | 2019 | 371 | 0.04 | Why? |
| Poly(ADP-ribose) Polymerases | 1 | 2017 | 91 | 0.04 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.04 | Why? |
| Magnetic Resonance Imaging | 4 | 2015 | 6551 | 0.04 | Why? |
| Histiocytosis, Langerhans-Cell | 1 | 1996 | 46 | 0.04 | Why? |
| Pilot Projects | 2 | 2019 | 5182 | 0.04 | Why? |
| Hypercholesterolemia | 1 | 2017 | 175 | 0.04 | Why? |
| Aging | 2 | 2017 | 3581 | 0.04 | Why? |
| Mental Disorders | 1 | 2019 | 6742 | 0.04 | Why? |
| Endometriosis | 1 | 2017 | 130 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Prostate | 1 | 1998 | 283 | 0.04 | Why? |
| Global Health | 1 | 2019 | 13911 | 0.04 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.04 | Why? |
| Aminoquinolines | 1 | 1995 | 63 | 0.04 | Why? |
| Visual Field Tests | 1 | 2015 | 77 | 0.04 | Why? |
| Rare Diseases | 1 | 2019 | 373 | 0.04 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.04 | Why? |
| Endocrinology | 1 | 2018 | 252 | 0.03 | Why? |
| Laparoscopy | 1 | 2006 | 1532 | 0.03 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.03 | Why? |
| Receptors, G-Protein-Coupled | 1 | 2017 | 309 | 0.03 | Why? |
| Tonometry, Ocular | 1 | 2015 | 108 | 0.03 | Why? |
| Infant | 1 | 2017 | 30274 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2009 | 9537 | 0.03 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.03 | Why? |
| Micronutrients | 1 | 2017 | 310 | 0.03 | Why? |
| Single-Blind Method | 1 | 2017 | 1283 | 0.03 | Why? |
| Longitudinal Studies | 3 | 2018 | 9893 | 0.03 | Why? |
| Visual Fields | 1 | 2015 | 123 | 0.03 | Why? |
| Thiazoles | 1 | 2018 | 496 | 0.03 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.03 | Why? |
| Thyroid Diseases | 1 | 2017 | 285 | 0.03 | Why? |
| Cardiomegaly | 1 | 1993 | 96 | 0.03 | Why? |
| Testosterone | 1 | 2019 | 596 | 0.03 | Why? |
| Stroke Volume | 2 | 2001 | 2153 | 0.03 | Why? |
| Chronic Disease | 2 | 2018 | 5139 | 0.03 | Why? |
| Gastrointestinal Neoplasms | 1 | 2017 | 392 | 0.03 | Why? |
| Infertility, Male | 1 | 2017 | 322 | 0.03 | Why? |
| Proton Pump Inhibitors | 1 | 2017 | 377 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Taste | 1 | 2017 | 715 | 0.03 | Why? |
| Intraocular Pressure | 1 | 2015 | 276 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 1014 | 0.03 | Why? |
| Circadian Rhythm | 1 | 2017 | 607 | 0.03 | Why? |
| Surveys and Questionnaires | 4 | 2021 | 43792 | 0.03 | Why? |
| Algorithms | 1 | 2008 | 7346 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Age Factors | 2 | 2017 | 21039 | 0.03 | Why? |
| Disease Management | 2 | 2019 | 6841 | 0.03 | Why? |
| Neoplasm Recurrence, Local | 1 | 2017 | 1063 | 0.03 | Why? |
| Polymorphism, Genetic | 1 | 2017 | 1074 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Gluconeogenesis | 1 | 2009 | 41 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2019 | 3395 | 0.02 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2018 | 3608 | 0.02 | Why? |
| Hyperplasia | 1 | 2009 | 204 | 0.02 | Why? |
| Gastrointestinal Tract | 1 | 2017 | 1113 | 0.02 | Why? |
| Practice Guidelines as Topic | 1 | 2014 | 15421 | 0.02 | Why? |
| Delayed Diagnosis | 1 | 2019 | 1529 | 0.02 | Why? |
| Safety | 1 | 2017 | 1583 | 0.02 | Why? |
| Visual Acuity | 1 | 2015 | 790 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Data Collection | 1 | 2018 | 1769 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2019 | 5440 | 0.02 | Why? |
| Autoantibodies | 1 | 1999 | 2094 | 0.02 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.02 | Why? |
| Follicle Stimulating Hormone | 1 | 2006 | 73 | 0.02 | Why? |
| Hyperglycemia | 1 | 2017 | 1363 | 0.02 | Why? |
| Diagnosis, Differential | 2 | 2013 | 7220 | 0.02 | Why? |
| Clinical Trials as Topic | 2 | 2018 | 7330 | 0.02 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 1996 | 2483 | 0.02 | Why? |
| Tomography, X-Ray Computed | 1 | 2013 | 25144 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.02 | Why? |
| Gastrointestinal Microbiome | 1 | 2017 | 1961 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Aerosols | 1 | 2020 | 5393 | 0.02 | Why? |
| Drug Resistance | 1 | 2006 | 395 | 0.02 | Why? |
| Diabetes Mellitus, Type 1 | 1 | 2017 | 1969 | 0.02 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.02 | Why? |
| Symptom Assessment | 1 | 2017 | 4967 | 0.02 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.02 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.01 | Why? |
| Cell Line | 1 | 2017 | 12040 | 0.01 | Why? |
| France | 1 | 2017 | 12074 | 0.01 | Why? |
| Water Deprivation | 1 | 1999 | 1 | 0.01 | Why? |
| Abortion, Spontaneous | 1 | 2006 | 776 | 0.01 | Why? |
| Deamino Arginine Vasopressin | 1 | 1999 | 19 | 0.01 | Why? |
| Preoperative Care | 1 | 2009 | 1515 | 0.01 | Why? |
| Petrosal Sinus Sampling | 1 | 1996 | 1 | 0.01 | Why? |
| beta-Endorphin | 1 | 1996 | 3 | 0.01 | Why? |
| Immunohistochemistry | 1 | 2005 | 2275 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2013 | 11304 | 0.01 | Why? |
| Prolactin | 1 | 1995 | 68 | 0.01 | Why? |
| Olfaction Disorders | 1 | 2013 | 3704 | 0.01 | Why? |
| Pyridostigmine Bromide | 1 | 1993 | 29 | 0.01 | Why? |
| Clonidine | 1 | 1993 | 31 | 0.01 | Why? |
| Neurosurgical Procedures | 1 | 2005 | 1738 | 0.01 | Why? |
| Communicable Disease Control | 1 | 2021 | 29620 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2007 | 22971 | 0.00 | Why? |
| Heart Ventricles | 1 | 1993 | 1139 | 0.00 | Why? |
| Ventricular Function, Left | 1 | 1993 | 1555 | 0.00 | Why? |